Normalax (Bisacodyl)

Bisacodyl, the active ingredient in Normalax, is a stimulant laxative presented as an oral tablet for oral use. It is indicated for the relief of occasional constipation in adults and for bowel preparation before certain medical procedures. It works by stimulating colonic peristalsis and increasing intestinal water secretion, which promotes bowel movements.

GNH USA supplies Normalax as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and regulatory requirements across multiple markets.

Bisacodyl is used to manage conditions that involve reduced bowel motility. - Constipation: provides relief of occasional constipation by stimulating intestinal peristalsis. - Bowel preparation: facilitates evacuation of the colon before diagnostic procedures such as colonoscopy. - Opioid‑induced constipation: helps counteract reduced motility caused by opioid therapy in adult patients.

Bisacodyl may cause a range of adverse reactions, varying from mild to severe. Common Side Effects: - Abdominal cramping - Diarrhea - Nausea Serious or Rare Side Effects: - Severe abdominal pain - Rectal bleeding - Dehydration

When using Bisacodyl, certain precautions should be observed to minimize risks and ensure safe use. - Assess hydration status: ensure adequate fluid intake before and during therapy. - Use lowest effective dose: start with the smallest recommended amount and adjust as needed. - Limit duration of use: avoid continuous use longer than one week without medical supervision. - Contraindicated in intestinal obstruction: do not use in patients with known bowel blockage. - Caution in electrolyte disorders: monitor potassium and other electrolytes during treatment. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Bisacodyl can interact with other medicines, affecting its efficacy or safety profile. Major Interactions (Avoid): - Loop diuretics: may exacerbate electrolyte depletion, increasing risk of cardiac arrhythmias. - Cardiac glycosides (e.g., digoxin): electrolyte shifts can heighten toxicity risk. Moderate Interactions (Monitor Closely): - Antacids: may reduce absorption of bisacodyl, diminishing its laxative effect. - NSAIDs: combined use can increase gastrointestinal irritation. - Calcium supplements: may interfere with the drug’s action on intestinal fluid balance.